logo

For the Inventor, By the Inventor

Seoul, South Korea

Lg Life Sciences, Limited


USPTO Granted Patents = 75

% Expired Patents = 37.3



Trademarks = 4

Forward Citations = 175

Loading Chart...
Loading Chart...

316 inventors (with patents filed for the assignee):

goldMedal Koo Lee (10 out of 14 patents)

silverMedal Heui Sul Park (8 out of 12 patents)

bronzeMedal Soon Ha Kim (7 out of 11 patents)

4.  Sung Bae Lee (7 out of 12 patents)

5.  Hyoung Jin Kim (7 out of 11 patents)

6.  Hyo Shin Kwak (6 out of 26 patents)

7.  Sang Dae Lee (6 out of 8 patents)

8.  Seung Hyun Yoon (6 out of 30 patents)

9.  Sun Young Koo (5 out of 7 patents)

10.  Dong Ook Seo (5 out of 5 patents)

11.  Eok Park (5 out of 5 patents)

12.  Dong Sup Shim (5 out of 5 patents)

13.  Hyun-Ik Shin (5 out of 6 patents)

14.  Sung Pil Choi (5 out of 11 patents)

15.  Soo Yong Chung (5 out of 9 patents)


Core Competencies:
Wound Infection Prevention
Sphingosine-1-Phosphate
Receptor Agonists
Dipeptidyl Peptidase-IV
Xanthine Oxidase Inhibitors
Caspase Inhibitors
Melanocortin Agonists
Nucleoside Phosphonates
Drug-Drug Interactions
Thrombin Inhibitors
Gene Families
Microparticle Formulations

75 patents:

1. 11311420 - Apparatus for wound infection prevention (2022-04-26),
2. 10085892 - Apparatus and method for wound infection prevention (2018-10-02),
3. 9540362 - Sphingosine-1-phosphate receptor agonists, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent (2017-01-10),
4. 9492118 - Pre-treatment process for electrochemical amperometric sensor (2016-11-15),
5. 9447044 - Thioaryl derivatives as GPR120 agonists (2016-09-20),
6. 9234211 - Hybrid promoter and recombinant vector comprising the same (2016-01-12),
7. 9161981 - Non-aqueous oily injectable formulation exhibiting preservative efficacy (2015-10-20),
8. 9091720 - Detection system using magnetic resistance sensor (2015-07-28),
9. 9000028 - Indole and indazole compounds as an inhibitor of cellular necrosis (2015-04-07),
10. 8889691 - Indole compounds as an inhibitor of cellular necrosis (2014-11-18),
11. 8859567 - Hydrate of 1-{(2S)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di-hydropyrido[3,4-D]pyrimidin-7(6H)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate (2014-10-14),
12. 8741927 - Production method of intermediate compound for synthesizing medicament (2014-06-03),
13. 8729273 - Compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same (2014-05-20),
14. 8569307 - Indole compounds as an inhibitor of cellular necrosis (2013-10-29),
15. 8481537 - Caspase inhibitors based of pyridazinone scaffold (2013-07-09),
LG Life Sciences, Limited is a global pharmaceutical company focused on research, development, manufacturing, and marketing of healthcare products. With a commitment to improving people's lives, LG Life Sciences aims to be a leading player in the pharmaceutical industry. They specialize in areas such as pharmaceuticals, vaccines, and diagnostics, providing innovative solutions for various medical needs. Please visit their website for more information.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

75 Patents

#100 in Seoul

#239 in South Korea

#9,983 in the World

Seoul, KR
Seoul, South Korea

Lg Life Sciences, Limited

Forward Citations = 175

316 inventors:

goldMedal Koo Lee (10 out of 14 patents)

silverMedal Heui Sul Park (8 out of 12 patents)

bronzeMedal Soon Ha Kim (7 out of 11 patents)

4.  Sung Bae Lee (7 out of 12 patents)

5.  Hyoung Jin Kim (7 out of 11 patents)

Please report any incorrect information to [email protected]
Loading…